Radiation Medication (Radium-223 Dichloride) Versus Radium-223 Dichloride Plus Radiation Enhancing Medication (M3814) Versus Radium-223 Dichloride Plus M3814 Plus Avelumab (a Type of Immunotherapy) for Advanced Prostate Cancer Not Responsive to Hormonal Therapy
Conditions:   Castration-Resistant Prostate Carcinoma;   Metastatic Prostate Carcinoma;   PSA Progression;   Stage IV Prostate Cancer AJCC v8;   Stage IVA Prostate Cancer AJCC v8;   Stage IVB Prostate Cancer AJCC v8 Interventions:   Drug: Avelumab;   Drug: Nedisertib;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration;   Radiation: Radium Ra 223 Dichloride Sponsor:   National Cancer ...
Source: ClinicalTrials.gov - August 27, 2019 Category: Research Source Type: clinical trials

Effects of Aging and Gender-Affirming Hormone Therapy on Vascular Endothelial Function and Metabolic Profiles in Transgender Women
Conditions:   Transgenderism;   Gender Identity;   Vascular Stiffness;   Vascular Inflammation;   Insulin Sensitivity;   Blood Pressure;   Lipid Disorder;   Appetitive Behavior Intervention:   Sponsors:   University of Colorado, Denver;   National Institutes of Health (NIH) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 26, 2019 Category: Research Source Type: clinical trials

Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life
Conditions:   Menopause;   Atherosclerosis;   Cardiovascular Diseases;   Estrogen Replacement Therapy Interventions:   Drug: Estradiol;   Other: Placebo Sponsors:   Hanna Savolainen-Peltonen;   University of Southern California Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Study of Truvada for HIV Pre Exposure Prophylaxis Using Daily Directly Observed Therapy to Look at Potential Interactions Between Truvada and Hormone Therapy
Conditions:   HIV Prevention;   Transgender Health Intervention:   Drug: 200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate Sponsors:   University of California, San Francisco;   San Francisco AIDS Foundation;   California HIV/AIDS Research Program Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life
Conditions:   Menopause;   Atherosclerosis;   Cardiovascular Diseases;   Estrogen Replacement Therapy Interventions:   Drug: Estradiol;   Other: Placebo Sponsors:   Hanna Savolainen-Peltonen;   University of Southern California Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Study of Truvada for HIV Pre Exposure Prophylaxis Using Daily Directly Observed Therapy to Look at Potential Interactions Between Truvada and Hormone Therapy
Conditions:   HIV Prevention;   Transgender Health Intervention:   Drug: 200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate Sponsors:   University of California, San Francisco;   San Francisco AIDS Foundation;   California HIV/AIDS Research Program Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life
Conditions:   Menopause;   Atherosclerosis;   Cardiovascular Diseases;   Estrogen Replacement Therapy Interventions:   Drug: Estradiol;   Other: Placebo Sponsors:   Hanna Savolainen-Peltonen;   University of Southern California Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Study of Truvada for HIV Pre Exposure Prophylaxis Using Daily Directly Observed Therapy to Look at Potential Interactions Between Truvada and Hormone Therapy
Conditions:   HIV Prevention;   Transgender Health Intervention:   Drug: 200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate Sponsors:   University of California, San Francisco;   San Francisco AIDS Foundation;   California HIV/AIDS Research Program Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life
Conditions:   Menopause;   Atherosclerosis;   Cardiovascular Diseases;   Estrogen Replacement Therapy Interventions:   Drug: Estradiol;   Other: Placebo Sponsors:   Hanna Savolainen-Peltonen;   University of Southern California Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Study of Truvada for HIV Pre Exposure Prophylaxis Using Daily Directly Observed Therapy to Look at Potential Interactions Between Truvada and Hormone Therapy
Conditions:   HIV Prevention;   Transgender Health Intervention:   Drug: 200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate Sponsors:   University of California, San Francisco;   San Francisco AIDS Foundation;   California HIV/AIDS Research Program Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life
Conditions:   Menopause;   Atherosclerosis;   Cardiovascular Diseases;   Estrogen Replacement Therapy Interventions:   Drug: Estradiol;   Other: Placebo Sponsors:   Hanna Savolainen-Peltonen;   University of Southern California Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Study of Truvada for HIV Pre Exposure Prophylaxis Using Daily Directly Observed Therapy to Look at Potential Interactions Between Truvada and Hormone Therapy
Conditions:   HIV Prevention;   Transgender Health Intervention:   Drug: 200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate Sponsors:   University of California, San Francisco;   San Francisco AIDS Foundation;   California HIV/AIDS Research Program Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life
Conditions:   Menopause;   Atherosclerosis;   Cardiovascular Diseases;   Estrogen Replacement Therapy Interventions:   Drug: Estradiol;   Other: Placebo Sponsors:   Hanna Savolainen-Peltonen;   University of Southern California Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Study of Truvada for HIV Pre Exposure Prophylaxis Using Daily Directly Observed Therapy to Look at Potential Interactions Between Truvada and Hormone Therapy
Conditions:   HIV Prevention;   Transgender Health Intervention:   Drug: 200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate Sponsors:   University of California, San Francisco;   San Francisco AIDS Foundation;   California HIV/AIDS Research Program Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life
Conditions:   Menopause;   Atherosclerosis;   Cardiovascular Diseases;   Estrogen Replacement Therapy Interventions:   Drug: Estradiol;   Other: Placebo Sponsors:   Hanna Savolainen-Peltonen;   University of Southern California Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Study of Truvada for HIV Pre Exposure Prophylaxis Using Daily Directly Observed Therapy to Look at Potential Interactions Between Truvada and Hormone Therapy
Conditions:   HIV Prevention;   Transgender Health Intervention:   Drug: 200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate Sponsors:   University of California, San Francisco;   San Francisco AIDS Foundation;   California HIV/AIDS Research Program Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials

Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life
Conditions:   Menopause;   Atherosclerosis;   Cardiovascular Diseases;   Estrogen Replacement Therapy Interventions:   Drug: Estradiol;   Other: Placebo Sponsors:   Hanna Savolainen-Peltonen;   University of Southern California Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2019 Category: Research Source Type: clinical trials